Results 261 to 270 of about 61,873 (283)
Some of the next articles are maybe not open access.

Performance of urinary NT-proBNP in ambulatory settings

Clinica Chimica Acta, 2022
NT-proBNP (N-terminal prohormone of brain natriuretic peptide) has been established as a useful biomarker in plasma for children with congenital heart disease (CHD). Plasma values were shown to correlate well with urinary values. We designed a study to investigate the general utility of urinary NT-proBNP in children with and without CHD in an ...
Nicole, Müller   +4 more
openaire   +2 more sources

NT-ProBNP: The Mechanism Behind the Marker

Journal of Cardiac Failure, 2005
Brain natriuretic peptide (BNP) was isolated originally from porcine brain extracts but was soon defined as a cardiac natriuretic hormone. Together with the highly homologous atrial natriuretic peptide, it forms a dual natriuretic peptide system of the heart. The main stimulus for proBNP synthesis and secretion from cardiac myocytes is myocyte stretch.
openaire   +3 more sources

NT‐proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT‐proBNP substudy

European Journal of Heart Failure, 2004
AbstractBackground:Neither profiles nor prognostic value of cardiac N‐terminal proBNP (NT‐proBNP) have been prospectively evaluated in a sufficient number of patients with severe chronic heart failure (CHF) treated with carvedilol or placebo.Methods:Baseline and follow‐up plasma concentrations of NT‐proBNP were measured in the European part of the ...
Hartmann, Franz   +12 more
openaire   +4 more sources

Nt‐proBNP in haemodialysis patients: A preliminary study

Scandinavian Journal of Clinical and Laboratory Investigation, 2008
N-terminal pro-brain natriuretic peptide (Nt-proBNP) is a marker of left ventricular function. Although many factors can increase left ventricular dysfunction in haemodialysis patients, the role of Nt-proBNP is uncertain.Serum concentrations of Nt-proBNP and troponin T were measured by electrochemiluminescence and C-reactive protein by ...
Alicia Pérez   +7 more
openaire   +3 more sources

Le NT-proBNP

2012
Present chez la plupart des mammiferes, le gene codant pour le BNP est situe sur le chromosome 1 (1p36.2) et se compose de 3 exons et de 2 introns chez l’Homme. Ce gene code une proteine de 134 acides amines (AA), le pre-proBNP1–134. Ce precurseur est transforme par clivage enzymatique de son peptide signal (26 AA) en proBNP1–108 (108 AA), une ...
openaire   +2 more sources

THE ROLE OF NT-PROBNP IN DIABETIC PATIENTS

Journal of Medicine and Pharmacy, 2012
Background: Moist Heat Sterilization validation process comprises several steps. The IQ, OQ have to follow the specified SOPs of manufacturer or equipment supplier. However, the efficiency of the sterilization process must be expressed in numberized values based on sterilization coefficient D, Z value, F value and SAL value.
Huu Dang Tran, Viet An Tran
openaire   +1 more source

BNP/NT‐ProBNP and Cardiac Pacing: A Review

Pacing and Clinical Electrophysiology, 2009
Natriuretic peptide (NP) levels (B‐type natriuretic peptide [BNP] and N‐terminal proBNP) are now widely used in clinical practice and cardiovascular research all over the world and have been incorporated into many cardiovascular guidelines for heart failure (HF).
Xiao-Rong Li, Ru-Xing Wang M.D., Tao Guo
openaire   +3 more sources

Effect of anemia on plasma concentrations of NT-proBNP

Clinica Chimica Acta, 2005
Concentrations of the amino-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) are increased in the blood of patients with heart failure. Understanding the variables that influence the concentrations of NT-proBNP is required to refine its clinical use criteria.
Monte S. Willis   +2 more
openaire   +3 more sources

NT-proBNP in Cardioembolic Stroke

Neurology India, 2023
Prahlad K, Sethi   +2 more
openaire   +2 more sources

The development of a metalloimmunoassay for the detection of NT-proBNP

2021
The purpose of this doctoral research is to develop a biosensor for the monitoring of heart failure (HF) in humans. Currently, there is no quantitative patient-facilitated method to monitor HF, and the physical symptoms that result are a poor representation of the acute state of the disease.
openaire   +3 more sources

Home - About - Disclaimer - Privacy